Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5UM1AI068613-16
LC: HIV PREVENTION TRIALS NETWORK
National Institutes of Health
Grant: 3UM1AI068617-20S1
HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy
National Institutes of Health
Grant: 3UM1AI068613-14S1
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)
National Institutes of Health
Grant: 5UM1AI068619-09
LOC: HIV Prevention Trials Network
National Institutes of Health
Grant: 5UM1AI068617-07
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network
FWCI
0.00
Citation Percentile
0.3%
Fields of Study
Keywords
Sustainable Development Goals